Control of viral replication and disease onset in cynomolgus monkeys by HIV-1 TAT vaccine

Journal of Biological Regulators and Homeostatic Agents

Volumn 14, Issue 1, 2000, Pages 22-26

  Ensoli, B ^a   Cafaro, A ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AIDS vaccine; Anti Tat CTL; HIV Tat; SHIV89.6P

Indexed keywords

CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; TRANSACTIVATOR PROTEIN; TRANSACTIVATOR PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; FOLLOW UP; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; HYPOTHESIS; IMMUNIZATION; IN VITRO STUDY; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MACACA; MONKEY; NONHUMAN; PRIMATE; PROTECTION; SKIN TEST; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA FASCICULARIS; PRIMATES; RNA VIRUSES;

EID: 0034457672     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. AIDS vaccine development in primate models
2. Why do we not have an HIV vaccine and how can we make one?
3. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus
4. Importance of the nef gene for maintenance of high virus loads and for development of AIDS
5. Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: Effects of vaccination with HIV-1 gp 120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 virus
6. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
7. Live-attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in Cynomolgus monkeys
8. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence
9. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques
10. The monkey's got AIDS: What now for live AIDS vaccine?
11. The trans-activator gene of human T lymphotropic virus type III (HTLV-III)
12. The trans-activator gene of HTLV-III is essential for virus replication
13. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein
14. Cellular uptake of the Tat protein from human immunodeficiency virus
15. Tat protein of HIV-1 stimulates growth of AIDS-Kaposi's sarcoma-derived cells
16. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: Implications for AIDS-Kaposi's sarcoma pathogenesis
17. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
18. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection
19. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains
20. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1
21. The Tat protein of human immunodeficiency virus type- 1, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing acid sequence
22. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness
23. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma development
24. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
25. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
26. Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes
27. Mode of AIDS immunopathogenesis based on the HIV-1 gp 120 and Tat-induced dysregulation of uninfected immune cells
28. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS
29. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the α5β3 integrins by mobilizing sequestered basic fibroblast growth factor
30. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of bFGF and αvβ3 integrin that are required for Tat activity
31. Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1
32. Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein
33. Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo
34. Release, uptake, and effects of extracellular HIV-1 Tat protein on cell growth and viral transactivation
35. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virus (SIV) proteins in SIV-infected macaques
36. Cytotoxic T lymphocyte activity in children infected with HIV
37. HIV-1 Rev and Tat specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS
38. Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide
39. Control of SHIV-89.6P infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
40. A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen
41. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact
42. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNFα), and TNF-β when they encounter their target antigens
43. Role of TNFα in CD8+ cytotoxic T lymphocyte-mediated lysis
44. Perforin, Fas/Fas ligand, and TNFα pathways as specific and by-stander killing mechanisms of hepatitis C virus-specific human CTL
45. A chimeric simian/human immunodeficiency virus type 1 isolate env causes in AIDS-like disease after in vivo passage in rhesus monkeys
46. Characterization of molecular cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys
47. Controlling HIV pathogenesis: The role of noncytotoxic anti-HIV activity of CD8- cells
48. Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV
49. Cell-derived anti-human immunodeficiency virus inhibitory factor
50. Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response
51. CD8+ cells from HIV-2-infected baboons control HIV replication